BioXcellence
  • Home
  • Contact Us
  • Facebook
  • Twitter
  • About us
    • Mission Statement
    • Customer Benefits
    • One-Stop-Shop
    • Our Team Approach
    • BD & KAM
    • Testimonials and Awards
    • Contact Us
  • Process Development
    • Expression Systems
    • Upstream Technology
      • Upstream Technology
      • Cell Culture Technology

        • Cell Culture Technology
        • BI-HEX®
        • conCERT™
        • Media Design & Optimization
      • Microbial Technology

        • Microbial Technology
        • Npro Autoprotease
        • Genome Integration
        • Yeast Expression
        • Pseudomonas Expression
        • Scaffold Platform
        • pDNA
    • Downstream Technology
      • Downstream Technology
      • BI-PurEX™
      • Crystallization
      • RAPPTor™
      • Half life extension
    • Tech Transfer & Scale Up
    • Process Validation
  • Contract Manufacturing
    • Track record
    • Capabilities & Capacities
    • cGMP Manufacturing
      • cGMP Manufacturing
      • Manufacturing Science and Technology
    • Manufacturing Plants
    • Project Management
    • Regulatory Support
    • Quality Assurance
      • Quality Assurance
      • Analytical development
  • Fill & Finish
    • Pharmaceutical Development
    • Dosage Form
      • Dosage Form
      • Liquid Vials
      • Prefilled Syringe
      • Mono- and Dual Chamber Cartridge
      • Lyophilization
    • Packaging
      • Packaging
      • BI-STAR™
  • Knowledge Center
    • Biotechnology
      • Biotechnology
      • About Biotechnology
      • History
      • Manufacturing Process at a Glance
      • Biotech Consulting
  • News and Press Releases
    • Press Releases
    • Upcoming Biotech Conferences
Press Releases Upcoming Biotech Conferences

Press Release

See below for our latest press releases about Boehringer Ingelheim BioXcellence™:

05.12.2012

Boehringer Ingelheim and Apexigen sign manufacturing agreement for process development and early stage clinical supply

13.11.2012

Boehringer Ingelheim and BaroFold Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology

12.11.2012

Boehringer Ingelheim enters strategic collaboration agreement to support Molecular Partner’s proprietary pipeline with clinical supply of DARPin® molecules

01.10.2012

Boehringer Ingelheim’s novel project transfer program enables fast track to launch for biopharmaceuticals

10.09.2012

Boehringer Ingelheim implements flexible fully disposable up- and downstream manufacturing for biopharmaceuticals

Further press releases

Contact Us

Boehringer Ingelheim BioXcellence - Contact Us

Do you have any inquiries, questions or comments? Please get in touch with us.

Contact Us
Back to top
  • BioXcellence
  • International Website
  • Sitemap
  • Imprint
  • Terms of Use
  • Print page
  • Recommend
Boehringer Ingelheim
© 2010 - 2013 Boehringer Ingelheim Pharma GmbH & Co KG. All rights reserved